We are live on ! Find out more

Large Cap
Drug Manufacturers - Specialty & Generic
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
TAK icon
1
Takeda Pharmaceutical
TAK
$69.1B
$69.1B $21.64 0.23%
TEVA icon
2
Teva Pharmaceutical Industries
TEVA
$49.7B
$49.7B $42.62 0.12%
HLN icon
3
Haleon
HLN
$39.7B
$39.7B $9.05 1.63%
ZTS icon
4
Zoetis
ZTS
$33.9B
$33.9B $83.48 1.08%
UTHR icon
5
United Therapeutics
UTHR
$24.9B
$24.9B $584.10 0.64%
VTRS icon
6
Viatris
VTRS
$23.4B
$23.4B $20.45 1.4%
NBIX icon
7
Neurocrine Biosciences
NBIX
$16.8B
$16.8B $165.92 0.37%
ELAN icon
8
Elanco Animal Health
ELAN
$12.9B
$12.9B $25.85 2.12%
RDY icon
9
Dr. Reddy's Laboratories
RDY
$12.3B
$12.3B $14.79 0.61%

Large Cap Drug Manufacturers - Specialty & Generic Stocks at a Glance

Specialty and generic drug manufacturers develop branded niche therapies, off-patent generics, and animal-health and cannabis products. Generics compete on price and manufacturing scale, while specialty brands carry pharma-like margins on smaller markets.

There are 9 large cap Drug Manufacturers - Specialty & Generic stocks — companies in the Drug Manufacturers - Specialty & Generic industry with a market cap between $10B and $200B — worth a combined $283B.

The largest by market cap are Takeda Pharmaceutical (TAK) at $69.1B, Teva Pharmaceutical Industries (TEVA) at $49.7B and Haleon (HLN) at $39.7B.

Among institutional investors, Takeda Pharmaceutical (TAK) drew the most net new fund positions in Q3 2026: 66 funds opened new positions, taking total fund holders up 13 (3.4%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q3 2026.